Single nucleotide polymorphisms of the interleukin-33 (IL-33) gene are associated with ankylosing spondylitis in Chinese individuals: a case–control pilot study

References

• Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369:1379–90.
   PubMed Web of Science ®Google Scholar
• Reveille JD, Sims AM, Danoy P, Evans DM, Leo P, Pointon JJ, Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010;42:123–7.
   PubMed Web of Science ®Google Scholar
• Ng SC, Liao Z, Yu DT, Chan ES, Zhao L, Gu J. Epidemiology of spondyloarthritis in the People’s Republic of China: review of the literature and commentary. Semin Arthritis Rheum 2007;37:39–47.
   PubMed Web of Science ®Google Scholar
• Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003;23:61–6.
   Google Scholar
• Ge R, Pan F, Liao F, Xia G, Mei Y, Shen B, Analysis on the interaction between IL-1F7 gene and environmental factors on patients with ankylosing spondylitis: a case-only study. Mol Biol Rep 2011;38:2281–4.
   PubMed Web of Science ®Google Scholar
• Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DCO, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973;1:904–7.
   PubMed Web of Science ®Google Scholar
• Khan MA, Ball EJ. Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol 2002;16:675–90.
   PubMed Web of Science ®Google Scholar
• Han GW, Zeng LW, Liang CX, Cheng BL, Yu BS, Li HM, Serum levels of IL-33 is increased in patients with ankylosing spondylitis. Clin Rheumatol 2011;30:1583–8.
   PubMed Web of Science ®Google Scholar
• Li GX, Wang S, Duan ZH, Zeng Z, Pan FM. Serum levels of IL-33 and its receptor ST2 are elevated in patients with ankylosing spondylitis. Scand J Rheumatol 2013;42:226–31.
   PubMed Web of Science ®Google Scholar
• Tahmasebi Z, Akbarian M, Mirkazemi S, Shahlaee A, Alizadeh Z, Amirzargar AA, Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus. Rheumatol Int 2013;33:2591–6.
   PubMed Web of Science ®Google Scholar
• van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361–8.
   PubMed Web of Science ®Google Scholar
• Wei JC, Wong RH, Huang JH, Yu CT, Chou CT, Jan MS, Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan. Clin Rheumatol 2007;26:1685–91.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009;19:519–23.
   Google Scholar
• Duan ZH, Pan FM, Zeng Z, Zhang TC, Wang S, Li GX, The FCGR2B rs10917661 polymorphism may confer susceptibility to ankylosing spondylitis in Han Chinese: a case-control study. Scand J Rheumatol 2012;41:219–22.
   PubMed Web of Science ®Google Scholar
• Sakashita M, Yoshimoto T, Hirota T, Harada M, Okubo K, Osawa Y, Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis. Clin Exp Allergy 2008;38:1875–81.
   PubMed Web of Science ®Google Scholar
• Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479–90.
   PubMed Web of Science ®Google Scholar
• Lee YH, Rho YH, Choi SJ, Ji JD, Song GG. Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis. J Hum Genet 2005;50:453–9.
   PubMed Web of Science ®Google Scholar
• Kurowska-Stolarska M, Hueber A, Stolarski B, McInnes IB. Interleukin-33: a novel mediator with a role in distinct disease pathologies. J Intern Med 2011;269:29–35.
   PubMed Web of Science ®Google Scholar
• Xu D, Jiang HR, Kewin P, Li Y, Mu R, Fraser AR, IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 2008;105:10913–18.
   PubMed Web of Science ®Google Scholar
• Ciccia F, Alessandro R, Rizzo A, Accardo-Palumbo A, Raimondo S, Raiata F, Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis. Rheumatology (Oxford) 2014;53:104–13.
   PubMed Web of Science ®Google Scholar
• Verri WA, Souto FO, Vieira SM, Almeida SC, Fukada SY, Xu D, IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis 2010;69:1697–703.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Netw 1994;5:517–31.
   PubMed Web of Science ®Google Scholar
• Valimaki E, Aittomaki S, Karenko L, Kantonen J, Pettersson T, Turunen U, Normal inflammasome activation and low production of IL-23 by monocyte-derived macrophages from subjects with a history of reactive arthritis. Scand J Rheumatol 2013;42:294–8.
   PubMed Web of Science ®Google Scholar
• Kim TH, Uhm WS, Inman RD. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 2005; 17:400–5.
   PubMed Web of Science ®Google Scholar
• Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, Martin MU. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci USA 2007;104:18660–5.
   PubMed Web of Science ®Google Scholar
• Cayrol C, Girard JP. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 2009;106:9021–6.
   PubMed Web of Science ®Google Scholar
• Pecaric-Petkovic T, Didichenko SA, Kaempfer S, Spiegl N, Dahinden CA. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009;113:1526–34.
   PubMed Web of Science ®Google Scholar
• Mok MY, Huang FP, Ip WK, Lo Y, Wong FY, Chan EY, Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 2010;49:520–7.
   PubMed Web of Science ®Google Scholar
• Hong YS, Moon SJ, Joo YB, Jeon CH, Cho ML, Ju JH, Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. J Korean Med Sci 2011;26:1132–9.
   PubMed Web of Science ®Google Scholar
• Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S. Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Clin Rheumatol 2011;30:825–30.
   PubMed Web of Science ®Google Scholar